Viking Therapeutics, Inc.
VKTX
Revenue
0.00
0.000.00%
3 Months ChangeAssets
715.73M
▼-23.69M▼-3.20%
3 Months ChangeLiabilities
76.67M
▲50.28M▲190.57%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-11
Form 8-K
ID: 0001193125-26-046536
2025-10-23
Form 10-Q
ID: 0001193125-25-247059
2025-10-22
Form 8-K
ID: 0001193125-25-246775
2025-08-19
Form 8-K
ID: 0001607678-25-000003
2025-07-23
Form 10-Q
ID: 0000950170-25-097950
2025-07-23
Form 8-K
ID: 0000950170-25-097885
2025-05-27
Form 8-K
ID: 0000950170-25-077865
2025-04-24
Form 10-Q
ID: 0000950170-25-058129
2025-04-23
Form 8-K
ID: 0000950170-25-057337
2025-04-23
Form 8-K
ID: 0000950170-25-057323